last of the big spenders haha. In comparison to the salaries management are getting these purchases are a drop in.the ocean. Gives me no faith in the company at all.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling